Serum orate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension

Journal of Hypertension

Volumn 18, Issue 1, 2000, Pages 97-101

  Lip, Gregory Y H ^a   Beevers, Michèle ^a   Beevers, D Gareth ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Malignant hypertension; Prognosis; Renal function; Survival; Uric acid (urate)

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; URATE; UREA; URIC ACID;

ADULT; ARTICLE; CAUSE OF DEATH; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; REGISTER; STATISTICAL ANALYSIS; STROKE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; AGING; BLOOD; BLOOD PRESSURE; KIDNEY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

AGED; AGING; BLOOD PRESSURE; CAUSE OF DEATH; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, MALIGNANT; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; UREA; URIC ACID;

EID: 0033621599     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018010-00014     Document Type: Article

References (20)

1. 1 Leishman AWD. Hypertension-treated and untreated: a study of 400 cases. BMJ 1959; i:1361-1363.
2. 2 Clough CG, Beevers DG, Beevers M. The survival of malignant hypertension in blacks, whites and Asians in Britain. J Hum Hypertens 1990; 4:94-96.
3. 3 Kincaid-Smith P. Malignant hypertension. J Hypertens 1991; 9:893-899.
4. 4 Lip GYH, Beevers M, Beevers DG. Survival and prognosis of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13:915-924.
5. 5 Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352:670-671.
6. 6 Frohlich ED. Uric acid: a risk factor for coronary heart disease. JAMA 1993; 270:378-379.
7. 7 Alderman MH, Cohen H, Madhaven S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-150.
8. 8 Wannamethee SG. Is serum uric acid a risk factor for coronary heart disease? J Hum Hypertens 1999; 13:153-156.
9. 9 Keith NM, Wegener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939; 196:332-339.
10. 10 Lip GYH, Beevers M, Beevers DG. The failure of malignant hypertension to decline: a survey of 24 years' experience. J Hypertens 1994; 12:1297-1305.
11. 11 Ahmed MEK, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. BMJ 1986; 292:235-237.
12. 12 The Coronary Drug Project Research Group. Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chron Dis 1976; 29:557-569.
13. 13 Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricaemia as a risk factor of coronary heart disease. The Framingham Study. Am J Epidemiol 1985; 121:11-18.
14. 14 Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997; 78:147-153.
15. 15 Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. Am J Epidemiol 1995; 141:637-644.
16. 16 Beevers DG, Lip GYH. Is uric acid really an independent cardiovascular risk factor? Lancet 1998; 352:1556
17. 17 Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first line therapy for hypertension in the elderly? JAMA 1998; 278:1901-1907.
18. 18 Beevers DG. Beta-blockers for hypertension: time to call a halt. J Hum Hypertens 1998; 12:807-810.
19. 19 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265:3255-3264.
20. 20 Isles C, Brown JJ, Cumming AMM, Lever AF, McAreavey D, Robertson JIS, et al. Excess smoking in malignant-phase hypertension. BMJ 1979; i:579-581.